Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/34079
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | BATEN, Evert | - |
dc.contributor.author | Van der Aa, F. | - |
dc.contributor.author | GOETHUYS, Hans | - |
dc.contributor.author | Slabbert, K. | - |
dc.contributor.author | ARIJS, Ingrid | - |
dc.contributor.author | VAN RENTERGHEM, Koenraad | - |
dc.date.accessioned | 2021-05-26T13:11:41Z | - |
dc.date.available | 2021-05-26T13:11:41Z | - |
dc.date.issued | 2021 | - |
dc.date.submitted | 2021-05-25T12:44:56Z | - |
dc.identifier.citation | World Journal of Urology, 39 (10), p. 3839-3844 | - |
dc.identifier.issn | 0724-4983 | - |
dc.identifier.uri | http://hdl.handle.net/1942/34079 | - |
dc.description.abstract | Purpose To determine whether omitting antimicrobial prophylaxis (AMP) in TURB is safe in patients undergoing TURB without an indwelling pre-operative catheter/nephrostomy/DJ and a negative pre-operative urinary culture. Materials and methods A multi-centered randomized controlled trial (RCT) from 17-09-2017 to 31-12-2019 in 5 hospitals. Patients with a pre-operative indwelling catheter/DJ-stent or nephrostomy and a positive pre-operative urinary culture (> 10(4) uropathogens/mL) were excluded. Post-operative fever was defined as body temperature >= 38.3 degrees C. A non-inferiority design with a 6% noninferiority margin and null hypothesis (H0) that the infection risk is at least 6% higher in the experimental (E) than in the control (C) group; H0: C (AMP-group) - E (no AMP-group) >= Delta (6% noninferiority margin). A multivariable, logistic regression was performed for AMP and post-TURB fever with covariates: tumor size and (clot-) retention. The R Project(R) for statistical computing was used for statistical analysis and a p value of 0.05 was considered as statistically significant. Results 459 Patients were included and 202/459 (44.1%) received AMP vs 257/459 (55.9%) without AMP. Fever occurred in 6/202 [2.9%; 95% CI (1.2-6.6%)] patients with AMP vs 8/257 [3.1%; 95% CI (1.5%-6.1%)] without AMP (p = 0.44). Multivariable, logistic regression showed no significant harm in omitting AMP when controlled for (clot-)retention and tumor size (p = 0.85) and an adjusted risk difference in developing post-TURB fever of 0.0016; 95% CI [- 0.029; 0.032]. Conclusion Our data suggest the safety of omitting AMP in patients undergoing TURB without an indwelling, pre-operative catheter/nephrostomy/DJ and a negative pre-operative urinary culture. | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.rights | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 | - |
dc.subject.other | TURB | - |
dc.subject.other | AMP | - |
dc.subject.other | Microbial resistance | - |
dc.subject.other | RCT | - |
dc.subject.other | Fever | - |
dc.subject.other | Antimicrobial stewardship | - |
dc.title | A randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB) | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 3844 | - |
dc.identifier.issue | 10 | - |
dc.identifier.spage | 3839 | - |
dc.identifier.volume | 39 | - |
local.format.pages | 6 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Baten, E (corresponding author), Associatie Urol Hageland, Kapellekensweg 10, Kessel Lo, Belgium.; Baten, E (corresponding author), Univ Hasselt, Martelarenlaan 45, B-3050 Hasselt, Belgium. | - |
dc.description.notes | Evert.baten@gmail.com | - |
dc.description.other | Baten, E (corresponding author), Associatie Urol Hageland, Kapellekensweg 10, Kessel Lo, Belgium ; Univ Hasselt, Martelarenlaan 45, B-3050 Hasselt, Belgium. Evert.baten@gmail.com | - |
local.publisher.place | ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1007/s00345-021-03694-6 | - |
dc.identifier.isi | WOS:000639060800002 | - |
dc.identifier.eissn | 1433-8726 | - |
local.provider.type | wosris | - |
local.uhasselt.uhpub | yes | - |
local.description.affiliation | [Baten, E.; Slabbert, K.] Associatie Urol Hageland, Kapellekensweg 10, Kessel Lo, Belgium. | - |
local.description.affiliation | [Van der Aa, F.; van Renterghem, K.] Univ Hosp Leuven, Dept Urol, Herestr 49, B-3000 Leuven, Belgium. | - |
local.description.affiliation | [Goethuys, H.] ZOL Genk, Genk, Belgium. | - |
local.description.affiliation | [Arijs, I] VIB, Ctr Canc Biol, B-3000 Leuven, Belgium. | - |
local.description.affiliation | [Baten, E.; van Renterghem, K.] Univ Hasselt, Martelarenlaan 45, B-3050 Hasselt, Belgium. | - |
local.description.affiliation | [van Renterghem, K.] Jessa Ziekenhuis, Dient Urol, Salvatorstr 20, B-3500 Hasselt, Belgium. | - |
local.uhasselt.international | no | - |
item.fulltext | With Fulltext | - |
item.contributor | BATEN, Evert | - |
item.contributor | Van der Aa, F. | - |
item.contributor | GOETHUYS, Hans | - |
item.contributor | Slabbert, K. | - |
item.contributor | ARIJS, Ingrid | - |
item.contributor | VAN RENTERGHEM, Koenraad | - |
item.fullcitation | BATEN, Evert; Van der Aa, F.; GOETHUYS, Hans; Slabbert, K.; ARIJS, Ingrid & VAN RENTERGHEM, Koenraad (2021) A randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB). In: World Journal of Urology, 39 (10), p. 3839-3844. | - |
item.accessRights | Restricted Access | - |
item.validation | ecoom 2022 | - |
crisitem.journal.issn | 0724-4983 | - |
crisitem.journal.eissn | 1433-8726 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s00345-021-03694-6.pdf Restricted Access | Published version | 561.65 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.